Introduction: The Vascular Challenge in Diabetes

Diabetes mellitus, a metabolic disorder characterized by chronic hyperglycemia, affects over 530 million adults worldwide. While the disease itself is manageable, its long-term complications—particularly cardiovascular disease—remain the leading cause of morbidity and mortality in this population. At the heart of this risk lies endothelial dysfunction: a breakdown in the inner lining of blood vessels that impairs blood flow regulation, promotes inflammation, and accelerates atherosclerosis. Clinicians and researchers continually seek adjunctive therapies that are safe, accessible, and effective. One such candidate is cod liver oil, a nutrient-dense supplement historically prized for its vitamin content but now recognized for its potential to improve endothelial function through multiple biological pathways. This article examines the mechanisms, evidence, and practical considerations of using cod liver oil to support vascular health in diabetic patients.

What Is Cod Liver Oil? Composition and Historical Background

Cod liver oil is extracted from the liver of Atlantic cod (Gadus morhua) and has been used for centuries as a traditional remedy for rickets, tuberculosis, and general weakness. Unlike fish oil derived from fatty fish like salmon or mackerel, cod liver oil is uniquely rich not only in long-chain omega-3 fatty acids—eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)—but also in high levels of preformed vitamins A and D. A typical teaspoon (5 mL) provides approximately 900 mcg of vitamin A (as retinol), 400 IU of vitamin D, and about 900 mg of total omega-3s, with a roughly 1:1 ratio of EPA to DHA.

Key Active Components

  • Omega-3 fatty acids (EPA and DHA): These polyunsaturated fats are precursors to specialized pro-resolving mediators (SPMs) such as resolvins and protectins, which actively dampen inflammation and promote tissue repair. They also integrate into cell membranes, influencing fluidity and receptor function.
  • Vitamin A (retinol): Essential for immune function, vision, and cellular differentiation. At moderate doses, retinol can modulate immune responses and may contribute to endothelial integrity.
  • Vitamin D: A secosteroid hormone that regulates calcium homeostasis and has pleiotropic effects on the cardiovascular system, including suppression of renin-angiotensin-aldosterone system activity and reduction of vascular inflammation.

The synergy of these three nutrients distinguishes cod liver oil from standard fish oil supplements, which typically lack significant vitamins A and D. However, this also necessitates careful dosing to avoid vitamin toxicity, especially in populations that may already consume fortified foods. Modern processing methods (molecular distillation) remove contaminants such as heavy metals and PCBs, making high-quality cod liver oil safe for long-term use when obtained from reputable manufacturers.

For historical context, cod liver oil was first scientifically studied in the 18th century, and by the early 20th century it became a staple in pediatric nutrition. Its recent resurgence in cardiovascular research is driven by the growing understanding of omega-3s as not merely anti-inflammatory but also as critical modulators of endothelial nitric oxide (NO) bioavailability.

Endothelial Function and Its Dysregulation in Diabetes

The endothelium comprises a monolayer of endothelial cells lining the entire circulatory system. Far from being a passive barrier, it is an active paracrine, autocrine, and endocrine organ that regulates vascular tone, hemostasis, inflammation, and angiogenesis. The key molecule in endothelial function is nitric oxide (NO), synthesized from L-arginine by endothelial nitric oxide synthase (eNOS). NO diffuses to adjacent vascular smooth muscle cells, activating guanylate cyclase and causing vasodilation. This process is termed endothelial-dependent vasodilation and is assessed clinically through techniques such as flow-mediated dilation (FMD) of the brachial artery or peripheral arterial tonometry.

How Diabetes Harms the Endothelium

Chronic hyperglycemia initiates a cascade of metabolic and signaling derangements:

  • Oxidative stress: Excess glucose drives mitochondrial overproduction of superoxide, which rapidly reacts with NO to form peroxynitrite, reducing NO bioavailability. Superoxide also damages lipids, proteins, and DNA, further impairing endothelial cell function.
  • Inflammation: Advanced glycation end-products (AGEs) and their receptors (RAGE) activate nuclear factor kappa-B (NF-κB), upregulating adhesion molecules (VCAM-1, ICAM-1) and pro-inflammatory cytokines (TNF-α, IL-6). This recruits leukocytes to the vessel wall, initiating atherosclerotic plaque formation.
  • Insulin resistance: Insulin normally stimulates eNOS through the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. In insulin-resistant states, compensatory hyperinsulinemia shifts signaling to the mitogen-activated protein kinase (MAPK) pathway, promoting vasoconstriction and proliferation of smooth muscle cells.
  • Endothelial glycocalyx degradation: The glycocalyx is a layer of proteoglycans and glycoproteins on the luminal surface that regulates permeability and shear stress sensing. Hyperglycemia and inflammation degrade it, exposing the endothelium to injury.

The net result is impaired vasodilation, increased permeability, a pro-coagulant state (via reduced thrombomodulin and increased plasminogen activator inhibitor-1), and accelerated atherosclerosis. Importantly, endothelial dysfunction is reversible in early stages with lifestyle and pharmacological interventions—hence the interest in adjuncts like cod liver oil.

Mechanisms of Cod Liver Oil in Enhancing Endothelial Function

Cod liver oil targets several of the pathogenic pathways described above. While the omega-3s are the primary active agents, vitamins A and D may contribute synergistic benefits.

Restoring Nitric Oxide Bioavailability

EPA and DHA are incorporated into endothelial cell membrane phospholipids, altering membrane fluidity and lipid raft composition. This modulates the activity of eNOS: studies show that omega-3s upregulate eNOS expression and enhance its phosphorylation at Ser1177 via the PI3K/Akt pathway, increasing NO production. Simultaneously, omega-3s reduce oxidative stress by decreasing NADPH oxidase activity and increasing antioxidant enzymes (superoxide dismutase, glutathione peroxidase). Less superoxide means less NO scavenging, thereby preserving NO bioactivity. In a 2013 randomized controlled trial, DHA supplementation (2 g/day for 6 weeks) improved FMD in overweight adults, an effect correlated with increased serum omega-3 index and reduced markers of oxidative stress.

Anti-Inflammatory and Pro-Resolving Actions

EPA and DHA are substrates for the synthesis of resolvins, protectins, and maresins—lipid mediators that actively resolve inflammation by reducing neutrophil infiltration, promoting macrophage efferocytosis, and inhibiting NF-κB signaling. In diabetic models, resolvin D1 has been shown to restore endothelial function by decreasing leukocyte–endothelial adhesion and improving NO-dependent vasodilation. Additionally, EPA competes with arachidonic acid for cyclooxygenase and lipoxygenase enzymes, shifting the balance from pro-inflammatory eicosanoids (e.g., PGE2, LTB4) to less inflammatory ones (e.g., PGE3, LTB5). Vitamin D also exerts anti-inflammatory effects by inhibiting T-helper 1 cell responses and downregulating pro-inflammatory cytokines.

Improving Vascular Reactivity and Reducing Stiffness

Beyond NO, cod liver oil may enhance endothelial function by reducing arterial stiffness—a hallmark of diabetic vasculopathy that occurs independently of overt atherosclerosis. Omega-3s improve elastic fiber composition and reduce collagen cross-linking, possibly through modulation of matrix metalloproteinases (MMPs). A meta-analysis of 41 trials found that fish oil supplementation significantly reduced pulse wave velocity (a measure of arterial stiffness) and improved augmentation index. The vitamin D component may also contribute by suppressing renin and lowering blood pressure, although evidence for a direct effect on endothelial function is less robust.

Summary of Mechanisms

In short, cod liver oil supports endothelial health through:

  • Upregulation of eNOS and increased NO production
  • Reduction of superoxide and oxidative stress
  • Synthesis of inflammation-resolving lipid mediators
  • Downregulation of adhesion molecules and NF-κB
  • Improvement in arterial stiffness and vascular compliance

It is important to note that while these mechanisms are well-supported in cellular and animal studies, human trials specifically in diabetic populations are limited but encouraging.

Review of Clinical Evidence in Diabetic Populations

Several randomized controlled trials and meta-analyses have investigated the effect of cod liver oil or its constituents on vascular function in type 2 diabetes. Although pure cod liver oil is studied less frequently than concentrated omega-3 supplements, the outcomes for endothelial markers are consistent enough to warrant clinical attention.

Key Studies

  • Gill et al. (2008): In a double-blind trial, type 2 diabetic patients received either cod liver oil (9 g/day providing ~1.7 g omega-3) or placebo for 12 weeks. The cod liver oil group showed a significant increase in brachial artery FMD (from 3.8% to 5.2%) along with a reduction in fasting triglycerides and a trend toward lower C-reactive protein. Thigh blood flow during reactive hyperemia also improved.
  • McLaughlin & Van Citters (2011): A study using DHA-rich oil (2.5 g/day) in overweight insulin-resistant individuals reported improved FMD and reduced soluble VCAM-1, an endothelial adhesion molecule. The improvement was correlated with increased membrane DHA content in erythrocytes.
  • Wang et al. (2017): A meta-analysis of 16 trials (1,087 participants with type 2 diabetes) found that omega-3 supplementation (fish oil or cod liver oil) improved FMD by an average of 2.12% (95% CI: 0.85%–3.39%) and reduced levels of E-selectin and ICAM-1. No significant effect was observed on PAI-1 or fibrinogen, suggesting the action is primarily on endothelial activation rather than coagulation.
  • Zarejan et al. (2020): A more recent trial in Iranian diabetic patients administered 2 g/day of omega-3 from cod liver oil for 12 weeks. They observed significant reductions in systolic blood pressure, pulse wave velocity, and an increase in serum NO metabolites. The improvement in arterial stiffness was correlated with the reduction in serum carboxymethyl lysine (a marker of AGEs).

Dose–Response and Duration

Across studies, effective doses for endothelial benefit range from 1.5 to 3 g/day of combined EPA+DHA, often from cod liver oil providing 800–1200 mg EPA+DHA plus vitamins A and D. The effects appear after 6–12 weeks and may persist with continued use. Lower doses may be insufficient, particularly in patients with poor baseline omega-3 status. It is worth noting that high doses (above 3 g/day) do not confer additional vascular benefit and may increase the risk of bleeding or gastrointestinal upset.

Limitations of Current Evidence

Most trials have short durations (≤6 months) and small sample sizes. Endothelial function is often a secondary endpoint, and many studies use surrogate markers (e.g., FMD, soluble adhesion molecules) rather than clinical outcomes like myocardial infarction or stroke. Furthermore, cod liver oil is rarely compared head-to-head with other omega-3 sources. The presence of vitamins A and D in cod liver oil confounds the interpretation of whether the benefits seen are attributable to omega-3s alone or to the combination. Despite these caveats, the evidence is sufficiently plausible to include cod liver oil as part of a comprehensive vascular risk reduction strategy in diabetics, provided safety is monitored.

Practical Considerations for Diabetic Patients

Before incorporating cod liver oil, diabetic individuals must weigh benefits against potential risks, especially given the pre-existing polypharmacy and comorbidities common in this population.

Dosage and Product Selection

  • Recommended dose: 1–2 teaspoons (5–10 mL) per day of cod liver oil, providing approximately 900–1800 mg total omega-3s (450–900 mg EPA + 450–900 mg DHA), plus 900–1800 mcg vitamin A and 400–800 IU vitamin D. This dose has shown efficacy in trials without exceeding the tolerable upper intake levels for vitamin A (10000 IU/day) or vitamin D (4000 IU/day) for adults.
  • Brand quality: Look for brands that use molecular distillation or short-path distillation to remove heavy metals, PCBs, and dioxins. Third-party testing seals (e.g., USP, NSF International, or independent lab certificates) are reliable. Avoid products that list “flavorings” or “artificial colors” as these may contain additives.
  • Forms: Liquid allows flexible dosing; softgels are convenient but often have added vitamin E as a preservative. Some patients prefer lemon-flavored liquid to mask the strong taste.

Safety Considerations

Vitamin Toxicity

Cod liver oil contains preformed vitamin A (retinol). The tolerable upper intake level for retinol is 3,000 mcg/day (10,000 IU) for adults. At typical doses (5–10 mL), vitamin A intake is within safe limits, but patients eating significant amounts of liver, fortified milk, or taking multivitamins should add up their daily intake. Chronic excess retinol can cause hepatotoxicity, bone pain, and teratogenicity (pregnancy). Vitamin D toxicity is rare below 4,000 IU/day. Diabetics with vitamin D deficiency may actually benefit from the additional 400–800 IU, but those on potent D2 supplements should check total intake.

Blood Thinning and Drug Interactions

High-dose omega-3s (≥3 g/day) can prolong bleeding time, but the modest doses in cod liver oil pose minimal risk on their own. However, diabetics often take antiplatelet agents (aspirin, clopidogrel) or anticoagulants (warfarin, rivaroxaban). In these cases, inform the physician before starting cod liver oil. Occasional monitoring of INR (for warfarin) is prudent initially. Fish oil does not potentiate warfarin at typical doses, but the theory of additive platelet inhibition warrants caution.

Blood Sugar Control

Early studies raised concerns that omega-3s might worsen glycemic control due to increased free fatty acids, but large meta-analyses have found no consistent effect on HbA1c or fasting glucose in type 2 diabetes. If anything, improved insulin sensitivity has been noted in some trials, possibly via reduced inflammation. Nonetheless, patients should monitor their blood glucose closely when starting any new supplement.

Integrating Cod Liver Oil into a Diabetic Lifestyle

Cod liver oil is not a replacement for antihypertensives, statins, or glucose-lowering medications. It is best used as an adjunct to:

  • A Mediterranean-style diet rich in vegetables, whole grains, legumes, and lean proteins.
  • Regular aerobic and resistance exercise, which independently boost NO production and endothelial function.
  • Adequate vitamin D status from sun exposure (when possible) and sensible supplementation, as deficiency is common in diabetics and worsens vascular outcomes.
  • Optimal glycemic control (HbA1c <7.0% for most adults) to minimize the toxic effects of hyperglycemia on the endothelium.

Patients should understand that benefits take weeks to accumulate and plateau after 3–6 months; consistency is key. Taking cod liver oil with a meal containing fat may improve absorption but is not strictly necessary because the oil itself is a source of fat.

Conclusion: A Pragmatic Adjunct for Vascular Protection

Endothelial dysfunction is a potentially reversible precursor to the devastating cardiovascular events that plague diabetic patients. Cod liver oil, through its rich content of omega-3 fatty acids and vitamins A and D, addresses several core mechanisms—oxidative stress, inflammation, and impaired NO signaling—that underpin this dysfunction. The clinical evidence, while still evolving, consistently shows improvements in flow-mediated dilation, arterial stiffness, and circulating markers of endothelial activation after several weeks of supplementation. With appropriate dosing and attention to safety—especially regarding vitamin A accumulation and drug interactions—cod liver oil can be a valuable, low-cost, and low-risk addition to the therapeutic arsenal.

Looking ahead, larger trials with hard outcomes are needed to confirm whether these vascular improvements translate into fewer myocardial infarctions, strokes, and amputations. Until then, the combination of a nutrient profile that supports the endothelium and a long history of safe use makes cod liver oil a sensible option for diabetic patients committed to optimizing their vascular health under medical supervision.

External resources for further reading: